Key Highlights
•
A new study found that the recombinant zoster vaccine (shingles vaccine) is linked to a significantly lower risk of developing dementia in adults aged 65 and older, with a 33% reduction in the first three years after vaccination.
Source →
•
The study also showed a reduced risk for Alzheimer’s disease and vascular dementia, suggesting the shingles vaccine could be a powerful and simple tool for public health dementia prevention.
Source →
•
Researchers successfully created “mini-brains” (neurospheres) from the urine of children with Dravet syndrome, a severe form of epilepsy, and identified unique protein patterns in these cells that correlate with the severity of each child’s condition.
Source →
•
This patient-specific model provides a groundbreaking way to study the biological reasons why Dravet syndrome affects some children more severely than others, opening the door to more personalized treatments.
Source →
•
A new study found that blocking a protein called HMGB1 in the brain can restore the growth of new brain cells and improve learning ability in adult rats that were exposed to heavy alcohol during adolescence.
Source →
•
This discovery points toward a potential future drug target to treat or reverse some of the lasting brain damage and cognitive problems caused by adolescent binge drinking, which affects millions of people.
Source →
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.
